Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria.
The purpose of these studies was to determine the molecular basis of the phenotypic mosaicism that is a defining feature of paroxysmal nocturnal hemoglobinuria (PNH). Analysis of T cell clones from a female patient revealed four distinct phenotypes based on surface expression of glycosyl phosphatidylinositol-anchored proteins (GPI-AP). When PIG-A (the gene that is mutant in PNH) from these clones was analyzed, four discrete somatic mutations were identified. Analysis of X chromosomal inactivation among the abnormal T cell clones was consistent with polyclonality. Together, these studies demonstrate that the phenotypic mosaicism that is characteristic of PNH is a consequence of genotypic mosaicism and that, at least in this case, PNH is a polyclonal rather than a monoclonal disease. That four distinct somatic mutations were present in a single patient suggests that in conditions that predispose to PNH PIG-A may be hypermutable.
Endo
M
M
Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84148 USA.
Ware
R E
RE
Vreeke
T M
TM
Singh
S P
SP
Howard
T A
TA
Tomita
A
A
Holguin
M H
MH
Parker
C J
CJ
D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications; D001483:Base Sequence; D002999:Clone Cells / Q000378:metabolism; D018076:DNA, Complementary / Q000235:genetics; D004303:Dosage Compensation, Genetic; D005260:Female; D017261:Glycosylphosphatidylinositols / Q000096:biosynthesis*; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics* / Q000502:physiology; D008969:Molecular Sequence Data; D009030:Mosaicism; D009154:Mutation; D010641:Phenotype; D013601:T-Lymphocytes / Q000378:metabolism*
D018076:DNA, Complementary; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; C080086:phosphatidylinositol glycan-class A protein